OverviewSuggest Edit

QIAGEN N.V., through its subsidiaries, provides technologies and products for preanalytical sample preparation and linked molecular assay solutions. The company also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. Technologies Sample Technologies: The company’s sample technologies provide access to the content of biological samples. These include solutions for the collection, stabilization, purification, handling and storage of any analyte (deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and protein) from any sample (blood, bone, and tissue).
TypePublic
Founded1984
HQHilden, DE
Websiteqiagen.com
Employee Ratings3.6
Overall CultureA+

Latest Updates

Employees (est.) (Nov 2020)5,300(+2%)
Job Openings305
Share Price (Nov 2020)€40.3
Cybersecurity ratingCMore

Key People/Management at Qiagen

Thierry Bernard

Thierry Bernard

Chief Executive Officer
Stéphane Bancel

Stéphane Bancel

Supervisory Director
Dominic O'Neil

Dominic O'Neil

Associate Director DNA Product Development
Stephany Foster

Stephany Foster

Senior Vice President, Head of Human Resources
Metin Colpan

Metin Colpan

Supervisory Director
Barthold Piening

Barthold Piening

Senior Vice President, Head of Global Operations
Show more

Qiagen Office Locations

Qiagen has offices in Hilden, Bodman-Ludwigshafen, Germantown, Holmesglen and in 19 other locations
Hilden, DE (HQ)
1 Qiagen Str.
Bodman-Ludwigshafen, DE
Bodenseeallee 20
Antwerpen, BE
Quellinstraat 49
Toronto, CA
4400-181 Bay St
Shenzhen Shi, CN
4 Kewen Rd, Nanshan Qu
København, DK
Fruebjergvej 3
Show all (27)

Qiagen Financials and Metrics

Qiagen Revenue

Market capitalization (12-Nov-2020)

9.1b

Closing stock price (12-Nov-2020)

40.3
Qiagen's current market capitalization is €9.1 b.
Show all financial metrics

Qiagen Cybersecurity Score

Cybersecurity ratingPremium dataset

C

75/100

SecurityScorecard logo

Qiagen Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Qiagen Online and Social Media Presence

Embed Graph

Qiagen Company Culture

  • Overall Culture

    A+

    85/100

  • CEO Rating

    C+

    70/100

  • Compensation

    A-

    79/100

Learn more on Comparably

Qiagen News and Updates

: Qiagen stock rises on announced COVID-19 test

Qiagen NV QGEN shares rose in the extended session Wednesday after the Netherlands-based medical diagnostics company said it will begin selling a portable COVID-19 test in the United States. Qiagen shares rose 4% after hours, following a 0.9% rise in the regular session to close at $46.51. Called t…

Qiagen to launch rapid coronavirus test it says could be used in airports and stadiums

Qiagen CEO Thierry Bernard said the antigen tests are meant to supplement, not replace, the molecular, or PCR, tests, the most accurate tests on the market.

Press release from Davidson Kempner regarding Qiagen

LONDON, Aug. 13, 2020 /PRNewswire/ -- Davidson Kempner is pleased that the majority of investors have rejected the wholly inadequate offer made by Thermo Fisher Scientific. The low acceptance level of 47.02% is a clear signal that there is widespread confidence in the long-term prospects...

Press release from Davidson Kempner regarding Qiagen

LONDON, Aug. 13, 2020 /PRNewswire/ -- Davidson Kempner is pleased that the majority of investors have rejected the wholly inadequate offer made by Thermo Fisher Scientific. The low acceptance level of 47.02% is a clear signal that there is widespread confidence in the long-term prospects...

Davidson Kempner Letter to Qiagen NV

LONDON, July 31, 2020 /PRNewswire/ -- To: Dr. Håkan Björklund (Chairman of the Supervisory Board) Stéphane Bancel (Supervisory Board Director) Dr. Metin Colpan (Supervisory Board Director) Prof. Dr. Ross Levine (Supervisory Board Director) Prof. Dr. Elaine Mardis (Supervisory Board...

Thermo Fisher May Need to Boost Qiagen Bid Again, Investor Says

Thermo Fisher May Need to Boost Qiagen Bid Again, Investor Says
Show more

Qiagen Blogs

New eBook! Interpreting NGS Tests for Inherited Disorders: 3 trends that will change everything

Today genetic innovation is advancing at breakneck pace. Since the first whole genome was sequenced in 2003, a feat that... The post New eBook! Interpreting NGS Tests for Inherited Disorders: 3 trends that will change everything appeared first on Bioinformatics Software and Services | QIAGEN Digital…

New Features and Functionalities of QCI Interpret

We are excited to announce the general availability of the Fall 2020 Release of QIAGEN Clinical Insight (QCI) Interpret. This... The post New Features and Functionalities of QCI Interpret appeared first on Bioinformatics Software and Services | QIAGEN Digital Insights.

New! QCI Interpret Translational for Human Exome Sequencing

Introducing QCI Interpret Translational, a new software solution for NGS variant assessment Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology... The post New! QCI Interpret Translational for Human Exome Sequencing appeared first on Bioinformatics Software and Services | …

Publication Roundup: QIAGEN CLC Genomics Workbench

Recently, there have been many noteworthy papers citing QIAGEN CLC Genomics Workbench, a comprehensive, easy-to-use toolbox that ensures continuity in... The post Publication Roundup: QIAGEN CLC Genomics Workbench appeared first on Bioinformatics Software and Services | QIAGEN Digital Insights.

Discover a specialized collection of viral ‘omics data to help advance your viral research

Are you a scientist or public health lab professional studying viral host response? Do you find it challenging to find... The post Discover a specialized collection of viral ‘omics data to help advance your viral research appeared first on Bioinformatics Software and Services | QIAGEN Digital Insigh…

Highlights of the latest update to QIAGEN CLC Microbial Genomics Module 20.1

Using viral reference databases for phylogeny construction and taxonomic profiling of samples with low viral load This blog tutorial highlights... The post Highlights of the latest update to QIAGEN CLC Microbial Genomics Module 20.1 appeared first on Bioinformatics Software and Services | QIAGEN Dig…
Show more

Qiagen Frequently Asked Questions

  • When was Qiagen founded?

    Qiagen was founded in 1984.

  • Who are Qiagen key executives?

    Qiagen's key executives are Thierry Bernard, Stéphane Bancel and Dominic O'Neil.

  • How many employees does Qiagen have?

    Qiagen has 5,300 employees.

  • Who are Qiagen competitors?

    Competitors of Qiagen include Integrated DNA Technologies, VWR and Access Biologicals.

  • Where is Qiagen headquarters?

    Qiagen headquarters is located at 1 Qiagen Str., Hilden.

  • Where are Qiagen offices?

    Qiagen has offices in Hilden, Bodman-Ludwigshafen, Germantown, Holmesglen and in 19 other locations.

  • How many offices does Qiagen have?

    Qiagen has 27 offices.